Find Clinical Trial

Exploratory Bioavailability of Three Formulations of Gliclazide MR Tablets 120 mg (I.R.I.S.) in Healthy Volunteers Under Fed Conditions (High Fat High Calorie Meal and Standard Meal)


← Back
Study Phase

Phase 1

Therapeutic Area

Metabolism

IndicationNo medical condition
SponsorInstitut de Recherches Internationales Servier (I.R.I.S.)
Active substance/
Medical device

GLICLAZIDE MR

Active Substance CodeS005190
Protocol CodeS005190-213
Eu CT2024-514298-23-00


Documents and links

Results are not yet available.




Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.



© 2025 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.
Accessibility